Acambis related Press Releases
Acambis reports positive data from trials of universal influenza A vaccine
Acambis reports positive data from trials of universal influenza A vaccine Cambridge, UK and Cambridge, Massachusetts – 3 January 2008 – Acambis plc (Acambis) (LSE: ACM), a leading vaccine Read more...
PRESS RELEASE: Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine
Acambis Joins Forces With Sanofi Pasteur to Develop West Nile Virus Vaccine CAMBRIDGE, England and CAMBRIDGE, Massachusetts, November 1 - No Human Vaccine Currently Exists Against the West Nile Read more...
PRESS RELEASE: FDA Approves ACAM2000 Vaccine for Protection Against Smallpox
FDA Approves ACAM2000 Vaccine for Protection Against Smallpox CAMBRIDGE, England and CAMBRIDGE, Massachusetts, September 3 /PRNewswire-FirstCall/ -- Acambis plc (Acambis) , a leading vaccine company, Read more...
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
